Television DTC ads must present major statement via concurrent audio and text

AI-verifiedblockerBinding lawCheckable — presence or a literal match settles it

Rule

For direct-to-consumer television-format advertisements (not radio) for prescription drugs intended for use by humans, the major statement must be presented concurrently using both audio and on-screen text (dual modality). This rule does not apply to advertisements exempt under 21 CFR 202.1(e)(2) — reminder advertisements (including price-reminder ads meeting § 200.200), bulk-sale drug advertisements, or prescription-compounding drug advertisements — which are exempt from all of paragraph (e)(1), including this dual-modality requirement, nor to veterinary drug advertisements or radio-only ads.

Check

First confirm scope: the piece is a television-format (not radio) DTC ad for a human prescription drug, and is not a reminder ad, price-reminder ad under §200.200, bulk-sale drug ad, or prescription-compounding ad exempt under (e)(2). If any exemption or exclusion applies, this rule does not fire. If in scope, confirm the major statement's audio narration and its on-screen text run at the same time (concurrent dual modality). Note: satisfying concurrency alone only establishes this element of clear-conspicuous-neutral presentation; the separate content requirement of (e)(1)(ii)(C)(1) (text must show verbatim key terms/phrases from the audio or the verbatim complete transcript) and the duration requirement of (e)(1)(ii)(C)(2) (text displayed long enough to be read easily, i.e., beginning/ending approximately with the corresponding audio) are assessed under separate rules, not this one.

Escalate when

Escalate when it is unclear whether the advertisement qualifies as an exempt reminder ad (including a §200.200 price-reminder ad), a bulk-sale drug ad, or a prescription-compounding ad, since that classification determines whether the dual-modality requirement applies at all; also escalate if the ad's classification as television vs. radio format, or as a human vs. veterinary drug product, is ambiguous.

Where this comes from

21 CFR 202.1(e)(1)(ii)(C). The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

…nspicuous, and neutral manner. The major statement is presented in a clear, conspicuous, and neutral manner if the following are met: (A) It is presented in consumer-friendly language and terminology that is readily understandable. (B) Its audio information, in terms of the volume, articulation, and pacing used, is at least as understandable as the audio information presented in the rest of the advertisement. (C) In advertisements in television format, it is presented concurrently using both audio and text (dual modality). To achieve dual modality: (1) Either the text displays the verbatim key terms or phrases from the corresponding audio, or the text displays the verbatim complete transcript of the corresponding audio; and (2) The text is displayed for a sufficient duration to allow it to be read easily. For purposes of the standard in this paragraph (e)(1)(ii)(C)(2), the duration is considered sufficient if the text display …

Open the original at these words on ecfr.gov ↗Read our full copy →

Document: 21 CFR 202.1
Version: 2026-09-16 — the link above is pinned to this date, so it shows the text as it stood then
Retrieved: 2026-09-21 from www.ecfr.gov
Fingerprint: a542640a872b3f2702d549e8…

Applies when

Naturepromotional

Mediumbroadcast

Audienceconsumer

Ad formattelevision

Intended specieshuman

Exemption statusnon-exempt

How this rule was checked

Citation proven by script and passed an independent verifier running on a different model. Not yet confirmed by a human.

Drafted
claude-sonnet-5 · 2026-09-21
Independent verification — revise
claude-opus-5 · 2026-09-21
Reviewer's reasons
- Supported: the quoted text is operative regulatory language, not an example or preamble. Although (e)(1)(ii) is phrased as 'The major statement is presented in a clear, conspicuous, and neutral manner if the following are met,' (e)(1)(i)(A) confirms the mandatory reading by allowing audio-only major statements 'unless required by paragraph (e)(1)(ii)(C) of this section to present the major statement using audio and text.' The rule statement and check follow from that.
- Not overstated in substance: the rule statement is confined to television DTC ads, matching (C)'s 'In advertisements in television format' and the chapeau's 'presented directly to consumers in television or radio format' for human drugs.
- Scope defect in applies_when: medium 'broadcast' plus audience 'consumer' will trigger on radio advertisements, but (e)(1)(ii)(C) applies only to television format. The check ('on-screen text') cannot be satisfied by a radio spot, so the rule as configured generates false blockers.
- Scope defect — missing exemption: (e)(2) exempts reminder advertisements, bulk-sale drug advertisements, and prescription-compounding advertisements 'from the requirements of paragraph (e)(1) of this section,' which encompasses (e)(1)(ii)(C). A television reminder or price-reminder ad would be wrongly flagged.
- Minor scope point: (e)(1)(ii) is limited to 'prescription drugs intended for use by humans,' whereas § 202.1 otherwise also reaches veterinary drugs; the consumer-audience condition largely covers this but the limit should be explicit.
- Atomic: the rule isolates the dual-modality concurrency requirement and does not bundle (C)(1) (verbatim key terms or complete transcript) or (C)(2) (sufficient display duration), which are separately checkable and appropriately left to other rules.
- Determinism correct: as scoped, the check turns on whether audio and on-screen text of the major statement are present at the same time — observable presence/absence. The judgment-laden elements of the provision (font/contrast 'read easily' in (D), interference in (E)) are not part of this rule.
- Authority correct: 21 CFR 202.1 is a regulation, so 'binding' is right; locator 21 CFR 202.1(e)(1)(ii)(C) matches the quoted sentence exactly.
- Severity 'blocker' is defensible: airing a TV DTC ad whose major statement lacks dual modality violates a mandatory presentation requirement and is not curable post-hoc.
Revised by the drafter
claude-sonnet-5 · 2026-09-21
Independent verification — pass
claude-opus-5 · 2026-09-21
Reviewer's reasons
- Supported: the quote is the operative text of (e)(1)(ii)(C), not an example or preamble. The chapeau of (e)(1)(ii) limits the provision to 'advertisements for prescription drugs intended for use by humans presented directly to consumers in television or radio format,' and (C) narrows to 'advertisements in television format' — exactly the scope the rule asserts.
- Not overstated: the obligation is binding in form. (e)(1)(ii) says the major statement 'must be presented in a clear, conspicuous, and neutral manner,' and the cross-reference in (e)(1)(i)(A) ('unless required by paragraph (e)(1)(ii)(C) of this section to present the major statement using audio and text') confirms (C) operates as a mandate, not a recommendation. The rule does not extend the requirement to radio, to professional audiences, or to veterinary drugs, all of which the source excludes.
- applies_when is justified and appropriately limited: human drug (per the section's opening definition distinguishing human vs. veterinary drugs), consumer/DTC and television format (per (e)(1)(ii) and (C)), broadcast medium, and non-exempt (per (e)(2), which exempts reminder, §200.200 price-reminder, bulk-sale, and prescription-compounding ads from all of paragraph (e)(1)). The rule's recitation of those exemptions matches the source text item for item.
- Atomic: the single checkable requirement is concurrent audio+text presentation. The rule expressly assigns the verbatim-text condition of (C)(1) and the sufficient-duration condition of (C)(2) to separate rules rather than bundling them, so no independent obligations are merged. The exemption language is scope, not an additional requirement.
- Determinism 'deterministic' is defensible: with the verbatim-content and duration sub-elements carved out to other rules, what remains is whether on-screen text of the major statement is present at the same time as the corresponding audio — an observable presence/absence question, not one of adequacy, prominence, or overall impression (unlike (D) or (E), which the rule correctly does not claim).
- Authority 'binding' is correct — 21 CFR 202.1 is a codified regulation.
- Locator 21 CFR 202.1(e)(1)(ii)(C) is precise and matches the quoted sentence. Severity 'blocker' is defensible: absence of dual modality in a DTC TV ad is a facial violation of the regulation that cannot be cured by other copy.
- The escalation triggers (ambiguous exempt-reminder/§200.200/bulk-sale/compounding status; ambiguous television vs. radio or human vs. veterinary classification) track exactly the scope conditions the source makes dispositive.